Off Patent
September 2027

Edurant

rilpivirine hydrochloride

Janssen Products LP

Tablet (oral) · NDA 202022

Last listed protection ends
September 15, 2027

The FDA lists 2 exclusivities for Edurant, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. New patient population exclusivity
    FDA code NPP
  2. Pediatric exclusivity
    FDA code PED